We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Makers Get Clarification on ANDA Data Submissions
Generics Makers Get Clarification on ANDA Data Submissions
November 10, 2009
Generic-drug makers have more clarification on where to send IND submissions for in vivo bioavailability and bioequivalence studies.